Werewolf Therapeutics, Inc. (HOWL)
Nasdaq: HOWL · CIK 0001785530 · United States
Every official Werewolf Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open HOWL filings
Werewolf Therapeutics, Inc. documents
- Werewolf Therapeutics, Inc. 10-K 2026HOWL 10-K 2026: annual report for fiscal 2026
- Werewolf Therapeutics, Inc. 10-K 2025HOWL 10-K 2025: annual report for fiscal 2025
- Werewolf Therapeutics, Inc. 10-K 2024HOWL 10-K 2024: annual report for fiscal 2024
- Werewolf Therapeutics, Inc. 10-K 2023HOWL 10-K 2023: annual report for fiscal 2023
- Werewolf Therapeutics, Inc. 10-K 2022HOWL 10-K 2022: annual report for fiscal 2022
- Werewolf Therapeutics, Inc. 10-Q 2026HOWL 10-Q 2026: quarterly report for fiscal 2026
- Werewolf Therapeutics, Inc. 10-Q 2025HOWL 10-Q 2025: quarterly report for fiscal 2025
- Werewolf Therapeutics, Inc. 10-Q 2024HOWL 10-Q 2024: quarterly report for fiscal 2024
- Werewolf Therapeutics, Inc. 10-Q 2023HOWL 10-Q 2023: quarterly report for fiscal 2023
- Werewolf Therapeutics, Inc. 10-Q 2022HOWL 10-Q 2022: quarterly report for fiscal 2022
- Werewolf Therapeutics, Inc. 8-K 2026HOWL 8-K 2026: current report for fiscal 2026
- Werewolf Therapeutics, Inc. 8-K 2025HOWL 8-K 2025: current report for fiscal 2025
- Werewolf Therapeutics, Inc. 8-K 2024HOWL 8-K 2024: current report for fiscal 2024
- Werewolf Therapeutics, Inc. 8-K 2023HOWL 8-K 2023: current report for fiscal 2023
- Werewolf Therapeutics, Inc. 8-K 2022HOWL 8-K 2022: current report for fiscal 2022
- Werewolf Therapeutics, Inc. DEF 14A 2026HOWL DEF 14A 2026: proxy statement for fiscal 2026
- Werewolf Therapeutics, Inc. DEF 14A 2025HOWL DEF 14A 2025: proxy statement for fiscal 2025
- Werewolf Therapeutics, Inc. DEF 14A 2024HOWL DEF 14A 2024: proxy statement for fiscal 2024
- Werewolf Therapeutics, Inc. DEF 14A 2023HOWL DEF 14A 2023: proxy statement for fiscal 2023
- Werewolf Therapeutics, Inc. DEF 14A 2022HOWL DEF 14A 2022: proxy statement for fiscal 2022
- Werewolf Therapeutics, Inc. Form 4 2026HOWL Form 4 2026: insider trading filing for fiscal 2026
- Werewolf Therapeutics, Inc. Form 4 2025HOWL Form 4 2025: insider trading filing for fiscal 2025
- Werewolf Therapeutics, Inc. Form 4 2024HOWL Form 4 2024: insider trading filing for fiscal 2024
- Werewolf Therapeutics, Inc. Form 4 2023HOWL Form 4 2023: insider trading filing for fiscal 2023
- Werewolf Therapeutics, Inc. Form 4 2022HOWL Form 4 2022: insider trading filing for fiscal 2022
- Werewolf Therapeutics, Inc. S-1 2026HOWL S-1 2026: registration statement for fiscal 2026
- Werewolf Therapeutics, Inc. S-1 2025HOWL S-1 2025: registration statement for fiscal 2025
- Werewolf Therapeutics, Inc. S-1 2024HOWL S-1 2024: registration statement for fiscal 2024
- Werewolf Therapeutics, Inc. S-1 2023HOWL S-1 2023: registration statement for fiscal 2023
- Werewolf Therapeutics, Inc. S-1 2022HOWL S-1 2022: registration statement for fiscal 2022
- Werewolf Therapeutics, Inc. 13F 2026HOWL 13F 2026: institutional holdings for fiscal 2026
- Werewolf Therapeutics, Inc. 13F 2025HOWL 13F 2025: institutional holdings for fiscal 2025
- Werewolf Therapeutics, Inc. 13F 2024HOWL 13F 2024: institutional holdings for fiscal 2024
- Werewolf Therapeutics, Inc. 13F 2023HOWL 13F 2023: institutional holdings for fiscal 2023
- Werewolf Therapeutics, Inc. 13F 2022HOWL 13F 2022: institutional holdings for fiscal 2022
More companies